Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward J Fox

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Expert Review of Neurotherapeutics|November 25, 2010
Alemtuzumab in the treatment of relapsing-remitting multiple sclerosisEdward J Fox
Neurology|December 30, 2004
Mechanism of action of mitoxantroneEdward J Fox
Neurology|December 30, 2004
Immunopathology of multiple sclerosisEdward J Fox
Clinical Therapeutics|June 6, 2006
Management of worsening multiple sclerosis with mitoxantrone: a reviewEdward J Fox
The American Journal of Managed Care|September 30, 2010
Emerging oral agents for multiple sclerosisEdward J Fox
Current Opinion in Neurology|March 9, 2012
New treatments and treatment goals for patients with relapsing-remitting multiple sclerosisEdward J Fox, Robert W Rhoades
Nature|August 1, 2014
Cancer: One cell at a timeEdward J Fox, Lawrence A Loeb
Seminars in Cancer Biology|October 12, 2010
Lethal mutagenesis: targeting the mutator phenotype in cancerEdward J Fox, Lawrence A Loeb
Neurology|December 30, 2004
Mitoxantrone for multiple sclerosis in clinical practiceSyed A Rizvi, Howard Zwibel, Edward J Fox
Geriatric Orthopaedic Surgery & Rehabilitation|June 30, 2025
Distal Radius Fractures as a Call to Action: Reducing Subsequent Fragility Fracture Risk Through Early Osteoporosis TherapyChenée Armando, Edward J Fox, Kenneth F Taylor
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Expert Review of Neurotherapeutics|November 25, 2010
Alemtuzumab in the treatment of relapsing-remitting multiple sclerosisEdward J Fox
Neurology|December 30, 2004
Mechanism of action of mitoxantroneEdward J Fox
Neurology|December 30, 2004
Immunopathology of multiple sclerosisEdward J Fox
Clinical Therapeutics|June 6, 2006
Management of worsening multiple sclerosis with mitoxantrone: a reviewEdward J Fox
The American Journal of Managed Care|September 30, 2010
Emerging oral agents for multiple sclerosisEdward J Fox
Current Opinion in Neurology|March 9, 2012
New treatments and treatment goals for patients with relapsing-remitting multiple sclerosisEdward J Fox, Robert W Rhoades
Nature|August 1, 2014
Cancer: One cell at a timeEdward J Fox, Lawrence A Loeb
Seminars in Cancer Biology|October 12, 2010
Lethal mutagenesis: targeting the mutator phenotype in cancerEdward J Fox, Lawrence A Loeb
Neurology|December 30, 2004
Mitoxantrone for multiple sclerosis in clinical practiceSyed A Rizvi, Howard Zwibel, Edward J Fox
Geriatric Orthopaedic Surgery & Rehabilitation|June 30, 2025
Distal Radius Fractures as a Call to Action: Reducing Subsequent Fragility Fracture Risk Through Early Osteoporosis TherapyChenée Armando, Edward J Fox, Kenneth F Taylor
Pageof 13